Francesco Bertoni

76PUBLICATIONS
230CO-AUTHORS
Haematological tumoursRheumatology and arthritisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (76)

|Nov 03, 2026
Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.

|Aug 31, 2026
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.

|Jun 26, 2026
BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?

|Jun 12, 2026
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.

|Jun 01, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.

|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Pageof 13

Frequent Collaborators

31 joint publications

Luciano Cascione

13 joint publications

Chiara Tarantelli

11 joint publications

Filippo Spriano

11 joint publications

Emanuele Zucca